| Literature DB >> 32154187 |
Berit Sletbakk Brusletto1,2, Else Marit Løberg2,3, Bernt Christian Hellerud4, Ingeborg Løstegaard Goverud2,3, Jens Petter Berg1,2, Ole Kristoffer Olstad1, Unni Gopinathan1,2, Petter Brandtzaeg1,2,5, Reidun Øvstebø1.
Abstract
Background: Patients developing meningococcal septic shock reveal levels of Neisseria meningitidis (106-108/mL) and endotoxin (101-103 EU/mL) in the circulation and organs, leading to acute cardiovascular, pulmonary and renal failure, coagulopathy and a high case fatality rate within 24 h. Objective: To investigate transcriptional profiles in heart, lungs, kidneys, liver, and spleen and immunostain key inflammatory cells and proteins in post mortem formalin-fixed, paraffin-embedded (FFPE) tissue samples from meningococcal septic shock patients. Patients andEntities:
Keywords: FFPE; IHC; MOF; Neisseria meningitidis; septic shock; transcriptional profiles
Mesh:
Year: 2020 PMID: 32154187 PMCID: PMC7045056 DOI: 10.3389/fcimb.2020.00042
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293
Overview of patients, clinical data, storage age of tissue, and type of tissue.
| 1 | 2.8 × 108 copies/mL (plasma) | 11 | FFPE | Lungs | 7.9 × 10e5 | Lungs | ||
| 2 | 3.8 × 107 copies/mL (plasma) | 10 | FFPE | Lungs | 1.0 × 10e6 | Lungs | ||
| 3 | 1.0 × 108 copies/mL (serum) | 5 | FFPE | Lungs | 2.1 × 10e7 | 2.4 × 10e8 | Lungs | Lungs |
| 4 | 3.0 × 107 copies/mL (serum) | 2 | FFPE | Lungs | 1.2 × 10e9 | 2.3 × 10e8 | Lungs | Lungs |
| 5 | 6 | FFPE | Lungs | 1.5 × 10e7 | 4.1 × 10e7 | Lungs | Lungs | |
| 6 | 15 | FFPE | 0 | Lungs | ||||
| 7 | 3 | FFPE | 0 | Lungs | ||||
The control patient was an elderly smoker.
not available.
Figure 1Correlation plots of the gene expression profiles between FF and FFPE tissue samples from meningococcal septic shock patients. The mean signal intensities for unfiltered gene expression (25000 transcripts) with NM (m-RNA) and NR (ncRNA) annotations on FF (x-axis) and FFPE (Y-axis) tissue samples for respectively lungs, heart, kidneys, liver and spleen. Pearson correlation coefficients (r) for each scatter plot are shown on the top.
Figure 2Immunohistochemical examination of FFPE tissue samples (lungs and heart) from one meningococcal septic shock patient and one control (acute non-infectious death). Immunohistochemical detection of CD68, MPO, MCP-1, and PAI-1 positive cells (labeled brown) in sections from lungs and heart from meningococcal septic shock patient and control patient with acute non-infectious death (Obj. x20) (#The control patient, elderly smoker).
Immunohistochemically examination of FFPE tissue samples (lungs and heart) from two patients with meningococcal septic shock and one control patient (acute non-infectious death).
| Lungs | Heart | Lungs | Heart | Lungs | Heart | ||
| CD68 | Macrophages/leukocytes | Large 160 Small 96 | 117 | Large 189 Small 76 | 99 | Large 57 Small 121 | 40 |
| MPO | Neutrophil granulocytes | 790 | 99 | 313 | 133 | 34 | 11 |
| CD3 | T-lymphocytes | 290 | 37 | 117 | 29 | 139 | 8 |
| CD20 | B-lymphocytes | 198 | 15 | 142 | 18 | 11 | 1 |
Immunohistochemical quantification of positive cells of CD68, MPO, CD3 and CD20 in sections from lungs and heart from meningococcal septic shock patients and control patient with acute non-infectious death (.
Figure 3Comparison of differentially expressed gene transcripts in FFPE tissue samples (lungs, heart, kidneys, liver, and spleen) from meningococcal septic shock patients vs. control patients (acute non-infectious death). Gene transcripts with signal values of <5 (log2) across all arrays were removed to filter for low and non-expressed genes. For expression comparisons of different groups, the profiles were compared using a one way ANOVA model. P-value <0.05, correction FDR 5%. The Venn diagram illustrate that 827 gene transcripts were specific for the lungs of the 2039 differentially expressed gene transcripts, in heart 982 of 2029, in kidneys 837 of 2231, in liver 559 of 1531 and in spleen 182 of 435. Five gene transcripts were common for lungs, heart, kidneys, liver, and spleen.
Top 10 differentially expressed up-regulated (A) and down-regulated (B) gene transcripts in large organs from patients with meningococcal septic shock vs. controls.
| TC16002035.hg.1 | MT1A | NM_005946 // RefSeq //Homo sapiens metal lothionein 1A (MTlA), mRNA. // chr16 //100 // | 0.004 | 13,526 |
| TC06003084.hg.1 | TNFAIP3 | AY820830 // NONCODE // accn=AY820830 class=mRNAlike lncRNA name=NULL ref=H-invitational | 0.029 | 10,872 |
| TC17000383.hg.1 | CCL2 | NM_002982 // RefSeq // Homo sapiens chemokine (C-C motif) ligand 2 (CCL2), mRNA. // chr | 0.008 | 10,100 |
| TC17002194.hg.1 | CSF3 | NR_033662 // NONCODE // accn=NR_033662 class=lncRNA name=ref=RefGeneNoncode transcript | 0.005 | 9,916 |
| TCOY000203.hg.1 | TCONS_00017657 // NONCODE // accn=NULL class lnciRNA=Human lincRNA ref=BodyMapLinc | 0.007 | 9,546 | |
| TC07000643.hg.1 | SERPINE1 | NM_000602 // RefSeq // Homo sapiens serpin peptidase inhibitor, clade E (nexin, plasmin | 0.009 | 7,339 |
| TC16002075.hg.1 | MT1L | NR_001447 // RefSeq // Homo sapiens metallothionein 1L (gene/pseudogene) (MT1L), non-co | 0.007 | 7,125 |
| TC0700190l.hg.1 | DQ573766 // NONCODE // accn=DQ573766 class=piRNA name=piR-41878 ref=NONCODE v2.0 transc | 0.011 | 7,122 | |
| TCOX001624.hg.1 | SAT1 | NR_027783 // NONCODE // accn=NR_027783 class=lncRNA name=ref=RefGeneNoncode transcript | 0.017 | 7,106 |
| TC16000469.hg.1 | MT1JP | NR_035677 // RefSeq // Homo sapiens metallothionein 1J, pseudogene (MTIJP), non-coding | 0.003 | 6,892 |
| TC01000807.hg.1 | uc021ooz.1 // UCSC Genes // A nucleics Acid regulating cell growth. // chr1 //100 // 1 | 0.035 | 12,671 | |
| TC17000383.hg.1 | CCL2 | NM_002982 // RefSeq // Homo sapiens chemokine (C-C motif) ligand 2 (CCL2), mRNA.// chr | 0.001 | 8,403 |
| TC19000464.hg.1 | HAMP | NM_021175 // RefSeq // Homo sapiens hepcidin antimicrobial peptide (HAMP},mRNA.// chr | 0.004 | 8,385 |
| TC01002205.hg.1 | NPPB | NM_002521 // RefSeq // Homo sapiens natriuretic peptide B (NPPB), mRNA. // chr1 // 100 | 0.007 | 8,341 |
| TC02003446.hg.1 | IL1RL1 | BC012580 // NONCODE // accn=BC012580 class=mRNAlike lncRNA name=NULL ref=H-invitational | 0.001 | 8,306 |
| TC04000408.hg.1 | CXCL8 | NM_000584 // RefSeq // Homo sapiens chemokine (C-X-C motif) ligand 8 (CXCL8), mRNA. // | 0.000 | 8,184 |
| TC0300060l.hg.1 | uc021xcv.1 // UCSC Genes // Sequence 827 from Patent W02010139812. // chr3 // 100 // 10 | 0.024 | 8,121 | |
| TC07001900.hg.1 | uc022aml.1 // UCSC Genes // Sequence 827 from Patent W02010139812. // chr7 // 100 // 10 | 0.024 | 8,121 | |
| TC14000567.hg.1 | uc021ryn.1 // UCSC Genes // Sequence 827 from Patent W02010139812. // chr14 // 100 // 1 | 0.024 | 8,121 | |
| TC20000115.hg.1 | uc021waz.1 // UCSC Genes // Sequence 827 from Patent W02010139812. // chr20 // 100 // 1 | 0.024 | 8,121 | |
| TC07000285.hg.l | DQ597235 // NONCODE // accn=DQ597235 class=piRNA name=piR-35301 ref=NONCODE v2.0 transc | 0.014 | 23,062 | |
| TC07001384.hg.1 | DQ599872 // NONCODE // accn=DQ599872 class=piRNA name=piR-37938 ref=NONCODE v2.0 transc | 0.014 | 23,062 | |
| TC07001404.hg.1 | DQ599872 // NONCODE // accn=DQ599872 class=piRNA name=piR-37938 ref=NONCODE v2.0 transc | 0.014 | 23,062 | |
| TC07001415.hg.1 | DQ599872 // NONCODE // accn=DQ599872 class=piRNA name=piR-37938 ref=NONCODE v2.0 transc | 0.016 | 21,738 | |
| TC01000006.hg.1 | DQ597235 // NONCODE // accn=DQ597235 class=piRNA name=piR-35301 ref=NONCODE v2.0 transc | 0.024 | 17,640 | |
| TC01001875.hg.l | DQ597235 // NONCODE // accn=DQ597235 class=piRNA name=piR-35301 ref=NONCODE v2.0 transc | 0.024 | 17,640 | |
| TC01002068.hg.1 | DQ599872 // NONCODE // accn=DQ599872 class=piRNA name=piR-37938 ref=NONCODE v2.0 transc | 0.024 | 17,640 | |
| TC01002070.hg.1 | DQ599872 // NONCODE // accn=DQ599872 class=piRNA name=piR-37938 ref=NONCODE v2.0 transc | 0.024 | 17,640 | |
| TC01003864.hg.1 | DQ599872 // NONCODE // accn=DQ599872 class=piRNA name=piR-37938 ref=NONCODE v2.0 transc | 0.024 | 17,640 | |
| TC07000363.hg.1 | DQ597235 // NONCODE // accn=DQ597235 class=piRNA name=piR-35301 ref=NONCODE v2.0 transc | 0.024 | 17,640 | |
| TC15000159.hg.1 | DQ575741 // NONCODE // accn=DQ575741 class=piRNA name=piR-43853 ref=NONCODE v2.0 transc | 0.027 | 8,740 | |
| TC15000185.hg.1 | DQ575741 // NONCODE // accn=DQ575741 class=piRNA name=piR-43853 ref=NONCODE v2.0 transc | 0.027 | 8,740 | |
| TC1S000960.hg.1 | DQ575741 // NONCODE // accn=DQ575741 class=piRNA name=piR-43853 ref=NONCODE v2.0 transc | 0.027 | 8,740 | |
| TC15001139.hg.l | DQ575741 // NONCODE // accn=DQ575741 class=piRNA name=piR-43853 ref=NONCODE v2.0 transc | 0.027 | 8,740 | |
| TC15001173.hg.1 | DQ575741 // NONCODE // accn=DQ575741 class=piRNA name=piR-43853 ref=NONCODE v2.0 transc | 0.027 | 8,740 | |
| TC09001260.hg.1 | DQ592725 // NONCODE // accn=DQ592725 class=piRNA name=piR-59837 ref=NONCODE v2.0 transc | 0.015 | 6,904 | |
| TC01002307.hg.1 | PLA2G2A | NM 000300 // RefSeq // Homo sapiens phospholipase A2, group IlA (platelets, synovial fl | 0.029 | 5,981 |
| TC10000517.hg.1 | DQ596518 // NONCODE // accn=DQ596518 class=piRNA name=piR-34584 ref=NONCODE v2.0 transc | 0.004 | 5,830 | |
| TC07001415.hg.1 | DQ599872 // NONCODE // accn=DQ599872 class=piRNA name=piR-37938 ref=NONCODE v2.0 transc | 0.048 | 5,387 | |
| TC04000834.hg.1 | uc021xue.l // UCSC Genes // A nucleics Acid regulating cell growth. // chr4 /1100 // 1 | 0.030 | 5,228 | |
| TC15000464.hg.1 | uc021snh.1 // UCSC Genes // Annexin Il and uses thereof. // chr15 // 100 //100 // 0 // | 0.049 | 10.048 | |
| TC1S000024.hg.1 | DQ592939 // NONCODE // accn=DQ582939 class=piRNA name=piR-50051 ref=NONCODE v2.0 transc | 0.025 | 7.334 | |
| TC1S000148.hg.1 | DQ592939 // NONCODE // accn=DQ582939 class=piRNA name=piR-50051 ref=NONCODE v2.0 transc | 0.025 | 7.334 | |
| TC15000207.hg.l | DQ592939 // NONCODE // accn=DQ582939 class=piRNA name=piR-50051 ref=NONCODE v2.0 transc | 0.025 | 7.334 | |
| TC15000238.hg.1 | DQ592939 // NONCODE // accn=DQ582939 class=piRNA name=piR-50051 ref=NONCODE v2.0 transc | 0.025 | 7.334 | |
| TC15000243.hg.1 | DQ592939 // NONCODE // accn=DQ582939 class=piRNA name=piR-50051 ref=NONCODE v2.0 transc | 0.025 | 7.334 | |
| TC15001014.hg.1 | DQ592939 // NONCODE // accn=DQ582939 class=piRNA name=piR-50051 ref=NONCODE v2.0 transc | 0.025 | 7.334 | |
| TC15001053.hg.1 | DQ592939 // NONCODE // accn=DQ582939 class=piRNA name=piR-50051 ref=NONCODE v2.0 transc | 0.025 | 7.334 | |
| TC15001115.hg.1 | DQ592939 // NONCODE // accn=DQ582939 class=piRNA name=piR-50051 ref=NONCODE v2.0 transc | 0.025 | 7.334 | |
| TC15001129.hg.1 | DQ592939 // NONCODE // accn=DQ582939 class=piRNA name=piR-50051 ref=NONCODE v2.0 transc | 0.025 | 7.334 | |
| TC06000232.hg.1 | uc021ypj.l // UCSC Genes // transfer RNA Val (anticodon AAC) // chr6 // 100 // 100 // 0 | 0.015 | −11,569 | |
| TCOX000897.hg.1 | uc022btp.l // UCSC Genes // transfer RNA Val (anticodon TAC) // chrX // 100 // 100 // 0 | 0.005 | −10,920 | |
| TC11001821.hg.1 | uc021qjo.l // UCSC Genes // transfer RNA Val (anticodon TAC) // chr11 // 100 // 100 // | 0.005 | −10,920 | |
| TC06000298.hg.1 | uc021ytf.l // UCSC Genes // transfer RNA Arg (anticodon CCG) // chr6 // 100 // 100 // 0 | 0.021 | −10,855 | |
| TC06001457.hg.1 | uc021ysp.1 // UCSC Genes // transfer RNA Arg (anticodon CCG) // chr6 // 100// 100 // 0 | 0.021 | −10,855 | |
| TC16000104.hg.1 | ucQ21tbd.1 // UCSC Genes // transfer RNA Arg (anticodon CCG) // chr16 // 100 // 100 // | 0.021 | −10,855 | |
| TC17000843.hg.1 | uc021ucu.l // UCSC Genes // transfer RNA Arg (anticodon TCG) // chr17 // 100//100 // | 0.017 | −10,120 | |
| TC06001414.hg.1 | uc021yqx.l // UCSC Genes // transfer RNA Val (anticodon AAC) // chr6 // 100 // 100 // 0 | 0.006 | −9,847 | |
| TC06000180.hg.1 | uc021ymv.1 // UCSC Genes // transfer RNA Arg (anticodon TCG) // chr6 // 100 // 100 // 0 | 0.039 | −9,792 | |
| TC06001445.hg.1 | ucQ21yrz.1 // UCSC Genes // transfer RNA Arg (anticodon TCG) // chr6 // 100 // 100 // 0 | 0.038 | −9,587 | |
| TC02001958.hg.1 | uc02lviy.l // UCSC Genes // Rfam model RF00005 hit found at contig region AC016700.8/16 | 0.045 | −4,841 | |
| TC16000732.hg.1 | uc021szx.1 // UCSC Genes // Rfam model RF00005 hit found at contig region AL022341.6/55 | 0.045 | −4,841 | |
| TC11000663.hR.1 | uc021qlw.1 // UCSC Genes // transfer RNA Ser (anticodon GCT) // chr11 // 100 // 100 // | 0.026 | −4,729 | |
| TC06001356.hg.1 | uc021ymw.1 // UC5C Genes // transfer RNA Ser (anticodon GCT) // chr6 // 100// 100 // 0 | 0.043 | −4,103 | |
| TC06001447.hg.1 | uc021ysa.1 // UCSC Genes // transfer RNA Ser (anticodon GCT) // chr6 // 100 // 100 // 0 | 0.043 | −4,049 | |
| TC15001239.hg.1 | uc021sji.1 // UC5C Genes // transfer RNA Ser (anticodon GCT) // chr15 // 100 // 100 // | 0.043 | −4,049 | |
| TC06000239.hg.1 | uc021yps.1 // UC5C Genes // transfer RNA Ser (anticodon GCT) // chr6 // 100 // 100 //0 | 0.043 | −3,939 | |
| TC16000947.hg.1 | uc021tes.1 // UCSC Genes // transfer RNA Leu (anticodon TAG) // chr16 // 100 // 100 // | 0.037 | −3,918 | |
| TC06000222.hg.1 | ucQ21yow.1 // UC5C Genes // transfer RNA Ser (anticodon GCT) // chr6 // 100 // 100 // 0 | 0.044 | −3,891 | |
| TC01000224.hg.1 | ucQ21ohh.1 // UC5C Genes // transfer RNA Asn (anticodon GTI) // chr1 // 100 // 100 // 0 | 0.048 | −3,830 | |
| TC07000285.hg.1 | DQ597235 // NONCODE // accn=DQ597235 class=piRNA name=piR-35301 ref=NONCODE v2.0 transc | 0.012 | −8,975 | |
| TC07001384.hg.1 | DQ599872 // NONCODE // accn=DQ599872 class=piRNA name=piR-37938 ref=NONCODE v2.0 transc | 0.012 | −8,975 | |
| TC07001404.hg.1 | DQ599872 // NONCODE // accn=DQ599872 class=piRNA name=piR-37938 ref=NONCODE v2.0 transc | 0.003 | −7,759 | |
| TC07001415.hR.1 | DQ599872 // NONCODE // accn=DQ599872 class=piRNA name=piR-37938 ref=NONCODE v2.0 transc | 0.014 | −7,563 | |
| TC01000006.hg.1 | DQ597235 // NONCODE // accn=DQ597235 class=piRNA name=piR-35301 ref=NONCODE v2.0 transc | 0.003 | −7,544 | |
| TC01001875.hg.1 | DQ597235 // NONCODE // accn=DQ597235 class=piRNA name=piR-35301 ref=NONCODE v2.0 transc | 0.003 | −7,544 | |
| TC01002068.hg.1 | DQ599872 // NONCODE // accn=DQ599872 class=piRNA name=piR-37938 ref=NONCODE v2.0 transc | 0.003 | −7,544 | |
| TC01002070.hg.1 | DQ599872 // NONCODE // accn=DQ599872 class=piRNA name=piR-37938 ref=NONCODE v2.0 transc | 0.049 | −7,522 | |
| TC01003864.hg.1 | DQ599872 // NONCODE // accn=DQ599872 class=piRNA name=piR-37938 ref=NONCODE v2.0 transc | 0.006 | −6,619 | |
| TC07000363.hg.1 | DQ597235 // NONCODE // accn=DQ597235 class=piRNA name=piR-35301 ref=NONCODE v2.0 transc | 0.006 | −6,619 | |
| TC11001821.hg.1 | ucQ21qjo.1 // UC5C Genes // transfer RNA Val (anticodon TAC) // chr11 // 100 // 100 // | 0.026 | −35,075 | |
| TCOX000897.hg.1 | uc022btp.1 // UC5C Genes // transfer RNA Val (anticodon TAC) // chrX // 100 // 100 // 0 | 0.026 | −35,075 | |
| TC06001414.hg.1 | ucQ21yqx.1 // UC5C Genes // transfer RNA Val (anticodon AAC) // chr6 // 100 // 100 // 0 | 0.008 | −32,753 | |
| TC06001418.hg.1 | ucQ21yrg.1 // UC5C Genes // transfer RNA Val (anticodon AAC) // chr6 // 100 // 100 // 0 | 0.020 | −32,128 | |
| TC05002164.hg.1 | ucQ21yke.1 // UC5C Genes // transfer RNA Val (anticodon AAC) // chr5 // 100 // 100 // 0 | 0.020 | −32,128 | |
| TC05001076.hg.1 | uc021yjv.1 // UC5C Genes // transfer RNA Val (anticodon AAC) // chr5 // 100 // 100 // 0 | 0.020 | −32,128 | |
| TC05001075.hg.1 | uc021yjt.1 // UCSC Genes // transfer RNA Val (anticodon AAC) // chr5 // 100 // 100 // 0 | 0.020 | −32,128 | |
| TC03000905.hg.1 | uc021xhc.1 // UCSC Genes // transfer RNA Val (anticodon Me) // chr3 // 100 // 100 // 0 | 0.020 | −32,128 | |
| TC06000194.hg.1 | ucQ21ynm.1 // UC5C Genes // transfer RNA Val (anticodon CAC) // chr6 // 100 // 100 // 0 | 0.020 | −31,406 | |
| TC05002166.hg.1 | ucQ21ykg.1 // UC5C Genes // transfer RNA Val (anticodon CAC) // chr5 // 100// 100 // 0 | 0.020 | −31,406 | |
| TC16000114.hg.1 | uc021tbt.1 // UCSC Genes // transfer RNA Pro (anticodon AGG) // chr16 // 100 // 100 // | 0.047 | −10,448 | |
| TC11002109.hg.1 | uc021qnm.1 // UCSC Genes // transfer RNA Pro (anticodon TGG) // chr11 // 100 // 100 | 0.035 | −9,303 | |
| TC01001076.hg.1 | ucQ21oty.1 // UC5C Genes // transfer RNA Asn (anticodon GTT) // chr1 // 100 // 100 // 0 | 0.024 | −5,623 | |
| TC01003178.hg.1 | ucQ21oxr.1 // UC5C Genes // transfer RNA Asn (anticodon GTT) // chr1 // 100 // 100 // 0 | 0.024 | −5,623 | |
| TC06001058.hg.1 | uc021zgl.l // UC5C Genes // transfer RNA Leu (antci odon TAA) // chr6 // 100 // 100 // 0 | 0.007 | −4,800 | |
| TC01001870.hg.1 | ENST00000365394 // ENSEMBL // RNA, 5S ribosomal pseudogene 77 [gene_biotype:rRNA transc | 0.020 | −4,307 | |
| TC03000086.hg.1 | ENST00000362739 // ENSEMBL // RNA, 5S ribosomal pseudogene 124 [gene_biotype:rRNA trans | 0.049 | −4,244 | |
| TC16000173.hg.1 | ucQ21tdf.1 // UC5C Genes // transfer RNA Thr (anticodon CGT) // chrl6 // 100 // 100 // | 0.041 | −4,242 | |
| TC15001029.hg.1 | DQ583164 // NONCODE // accn=DQ583164 class=piRNA name=piR-50276 ref=NONCODE v2.0 transc | 0.010 | −3,899 | |
| TC18000391.hg.1 | DQ583164 // NONCODE // accn=DQS83164 class=piRNA name=piR-50276 ref=NONCODE v2.0 transc | 0.010 | −3,899 | |
Gene transcripts with maximal signal values of < 5 (log2) across all arrays were removed to filter for low and non-expressed genes. The table displays transcripts ID (affymetrix ID), gene symbol; mrna assignment, P-values and Fold Changes values.
Numbers of genes differentially expressed (A) and functional analysis (B) in organs from patients with meningococcal septic shock (n = 5) performed by IPA.
| 2039 | 2029 | 2231 | 1531 | 435 | |
| Up-regulated | 331 | 458 | 421 | 130 | 74 |
| Down–regulated | 519 | 48 | 316 | 758 | 64 |
| Mapped ID eligible for IPA-analysis | 850 | 506 | 737 | 888 | 138 |
| 171 | 223 | 164 | 207 | 39 | |
| Molecules | Molecules | Molecules | Molecules | Molecules | |
| Cellular movement | 47 | 79 | 33 | ||
| Cell-To-Cell signaling and interaction | 38 | 51 | 4 | ||
| Cell death and survival | 66 | 119 | 73 | 38 | |
| Cellular development | 56 | ||||
| Cellular growth and proliferation | 59 | ||||
| Protein synthesis | 44 | 37 | |||
| Gene expression | 65 | 37 | |||
| Lipid metabolism | 34 | ||||
| Small molecular biochemistry | 46 | ||||
| Vitamin and mineral metabolism | 19 | ||||
| Cell morphology | |||||
| Cellular compromise | 15 | 5 | |||
| Molecular transport | 24 | ||||
| Amino acid metabolism | 1 | ||||
| Cell cycle | 5 | ||||
| Cellular assembly and organization | 7 | ||||
| Molecules | Molecules | Molecules | Molecules | Molecules | |
| Hematological system development and function | 47 | 68 | 31 | 4 | |
| Immune cell trafficking | 38 | 49 | 17 | 2 | |
| Tissue development | 41 | 47 | |||
| Skeletal and muscular system development and function | 25 | ||||
| Cardiovascular system development and function | 37 | 23 | 26 | ||
| Organismal survival | 85 | 49 | |||
| Tissue morphology | 64 | ||||
| Organ morphology | 14 | 3 | |||
| Organismal development | 40 | 7 | |||
| Digestive system development and function | 13 | ||||
| Hepatic system development and function | 10 | ||||
| Embryonic development | 16 | ||||
| Reproductive system development and function | 5 | ||||
Functional analysis performed with IPA; filtering criteria: FC ≥|±2|, p < 0.05. P-value of overlap comparing values from meningococcal septic shock (n = 5) patients with controls (n = 2).
The genes eligible for IPA analysis are identified by Ingenuity Knowledge Base.
Molecules may refer to any gene, RNA or protein.
Figure 4Predicted biofunctions (A), canonical pathways (B), and upstream regulators (C) in FFPE tissue samples from patients with meningococcal septic shock. ≪Comparison analysis≫ of biofunctions, canonical pathways, and upstream regulators significantly enriched in FFPE tissue samples from lungs, heart, kidneys, liver and spleen from meningococcal septic shock patients vs. controls patients (acute non-infectious death). The figure shows the most up-regulated biofunctions (A), canonical pathways (B), and upstream regulators (C) ranked according to expression levels in FFPE tissues from lungs. The Z-score indicates predicted activation state of the biofunctions, canonical pathways, and upstream regulators. Z-score value >|±1| are displayed. Blue color or lighter shades of blue indicate a negative Z-score and down-regulation of a biofunction, canonical pathways, and upstream regulators. Orange or lighter shades of orange indicates a positive Z-score and up-regulation of a biofunction, canonical pathways, and upstream regulators. Note that only the top pathways are shown.
Figure 5Predicted gene signaling pathways from the top up-regulated (A) and down-regulated (B) canonical pathways in FFPE tissue samples from patients with meningococcal septic shock vs. controls. The Z-score indicates predicted activation state of canonical pathways. Orange or lighter shades of orange indicate a positive Z-score and up-regulation of the pathway. Blue color or lighter shades of blue indicate a negative Z-score and down-regulation of the pathway. The transcripts in the gene signaling pathway are expressed as Fold Change (FC) values. Red or lighter shades of red indicates positive FC-values and up-regulation of transcripts, green color or lighter shades of green indicates negative FC- values and down-regulation of transcripts. Color gray indicates that a predicted activation state of a gene/transcript in the canonical pathway signaling network is not affected.
Top upstream regulators differentially expressed in organs from five patients with meningococcal septic shock vs. controls.
| Top upstream regulators | TNF 2.32E-25 (Activated) | MYCN 3.39E-35 (Activated) | RICTOR 9.08E-17 (Inhibited) | RXRA 4.68E-11 | CREB1 1.81E-04 |
| IL1B 7.77E-20 (Activated) | MYC 3.01E-24 (Activated) | NFE2L2 1.34E-09 (Activated) | ACOX1 7.64E-09 | SBDS 3.45E-04 | |
| IL-13 8.34E-20 | IL1B 9.38E-21 (Activated) | MYCN 1.67E-09 (Activated) | PPARA 2.23E-07 | miR-4668-3p 5.22E-04 | |
| NFkB (complex) 4.81E-19 (Activated) | TNF 1.15E-20 (Activated) | IL1A 3.16E-08 (Activated) | APP 4.20E-07 | miR-17-2-3p 5.91E-04 | |
| IL1A 1.13E-18 (Activated) | IL3 2.47E-18 (Activated) | TNF 3.25E-08 (Activated) | PPARGC1A 4.32 E-07 | ATF4 1.48-03 |
Functional analysis performed by IPA. P-values of overlap comparing values from meningococcal septic shock (n = 5) patients with controls (n = 2). Predicting activation or inhibition (filtering criteria: FC ≥|±2|, p < 0.05).
Figure 6Transcriptional profiles of canonical pathways in FFPE tissue samples from meningococcal septic shock patients. The figure displays the top canonical pathways enriched in each organ. The mean values of N. meningitidis DNA/μg human DNA was in lungs: 2.5 × 108, heart 5.4 × 107, kidneys 4.6 × 106 liver 8.3 × 107, and spleen 9.4 × 104. A ≪core analysis≫ was performed separately for each organ. Significantly enriched canonical pathways were identified with a right-tailed Fisher's Exact Test (p < 0.05, after correction for multiple testing using the Benjamini-Hochberg method). Ratio denotes the number of significantly expressed genes compared with the total number of genes associated with the canonical pathway. The Z-score=|±1| indicates predicted activation state of canonical pathway. Blue color or lighter shades of blue indicate a negative Z-score and down-regulation of the pathway, and orange or lighter shades of orange indicate a positive Z-score and up-regulation of the pathway. Gray color indicates no activity pattern available. Z-score value >|±1| are displayed.
Figure 7Interaction networks of top score canonical pathways and transcripts affected in FFPE tissue samples from meningococcal septic shock patients. The interaction networks in lungs (A), heart (B), kidneys (C), liver (D), and spleen (E) are generated through the use of IPA ≪core analysis≫. In addition, ≪Canonical Pathways Analysis≫ was performed to determine genes that were involved in well-documented canonical signal transduction or metabolic pathways, from the library of canonical pathways in IPA. Benjamini–Hochberg procedure for multiple testing corrections was performed. Significantly enriched genes in the dataset were overlayed into the specific canonical pathway. The analysis was performed in silico using Molecular Activity Predictor analysis of IPA. The shapes represent the molecular classes of the ≪gene≫. In the figures, red represents upregulation and green down-regulation, and color intensity represents the relative magnitude of change in gene expression. Gray color indicates no activity pattern available. Direct and indirect interactions are indicated by solid and dashed lines, respectively. The network diagram shows the biological relationship between the indicated genes lines: — represents direct physical interactions; —– represents indirect functional interactions; → represents activation; ⊣ represents inhibition. The blue lines indicate that the direction of regulation is consistent with IPA prediction. In contrast, yellow lines indicate that the regulation observed is inconsistent with expectations, while gray lines indicate lack of pre-existing data to formulate expectations. Nodes are displayed using various shapes that represent the functional class of the genes.
Figure 8Cytokine concentration in fresh frozen tissue samples from patients with meningococcal septic shock (n = 3). The concentration unit is ng/g for the organ samples.
Figure 9Predicted gene signaling network from the top up-regulated (A) and down-regulated (B) upstream regulators in FFPE tissue samples from patients with meningococcal septic shock vs. controls. The Z-score indicates predicted activation state of genes in the upstream regulator signaling network. Orange or lighter shades of orange indicate a positive Z-score and up-regulation of the upstream regulator. Blue color or lighter shades of blue indicate a negative Z-score and down-regulation of the upstream regulator. The transcripts in the signaling network are expressed as Fold Change (FC) values. Red or lighter shades of red indicates positive FC-values and up-regulation of transcripts, green color or lighter shades of green indicates negative FC-values and down-regulation of transcripts. Color gray indicates that a predicted activation state of a gene/transcript in the upstream regulator signaling network is not affected.